01—Abstract
Summary
Summary of the 8-K filed April 29, 2021. Cited figures are marked; the original filing is the authoritative source.
Moderna, Inc. (MRNA) filed an 8-K on April 29, 2021, reporting the results of its 2021 Annual Meeting of Stockholders held on April 28, 2021.
The meeting confirmed a quorum and saw decisive votes on key proposals, indicating strong shareholder support for the company's leadership and operational decisions. Key outcomes include the re-election of directors, advisory approval of executive compensation, and the ratification of the company's independent auditor. These results generally reflect shareholder confidence in the current board and financial oversight, which is crucial for a company navigating significant growth and development in the biotechnology sector.
02—Key points
Key Highlights
- All proposed directors, including Robert Langer, Elizabeth Nabel, and Elizabeth Tallett, were elected to serve three-year terms.
- Stockholders provided advisory approval for the compensation of Moderna's named executive officers.
- Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
- The meeting had a quorum present, signifying sufficient shareholder participation.
- The voting outcomes demonstrate significant shareholder support for the company's board and its financial auditing partner.
03—Questions
Frequently Asked Questions
What were the main outcomes of Moderna's 2021 Annual Meeting of Stockholders?
The main outcomes were the election of directors, advisory approval of executive compensation, and the ratification of Ernst & Young LLP as the independent auditor for 2021. A quorum was present for the meeting.
Did the shareholders approve the election of the proposed directors?
Yes, all nominated directors—Robert Langer, Elizabeth Nabel, and Elizabeth Tallett—were elected by a significant majority of votes.
How did shareholders vote on executive compensation?
Shareholders approved the compensation of the named executive officers on a non-binding, advisory basis with a substantial 'For' vote.
Was the appointment of the independent auditor ratified?
Yes, the appointment of Ernst & Young LLP as Moderna's independent registered public accounting firm for 2021 was ratified by the stockholders with a high percentage of 'For' votes.
04—Continue